RecruitingPhase 1NCT05652335
55
studies recruiting now
as of 7 Sept 2026
299
studies registered in total
as of 7 Sept 2026
11
countries with a recruiting site
as of 7 Sept 2026
10 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT06569147
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
RecruitingPhase 1 / Phase 2NCT05145816
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RecruitingPhase 1 / Phase 2NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
RecruitingPhase 2NCT07638683
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 55 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Primary systemic amyloidosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Primary systemic amyloidosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Melphalan (Alkeran)
Phase 3Dexamethasone (Aeroseb-dex)
Phase 2Etanercept (Benepali)
Phase 2Melphalan Hydrochloride (Alkeran)
Phase 2Thalidomide (Kevadon)
Phase 2Lenalidomide (Lenalidomide accord)
Phase 2Doxycycline (Doxirobe)
Phase 1Dezamizumab
+ 2 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).